Search research articles
Contact Us
Filters
Showing results (101-110 of 111) with videos related to
Page
of 12
Sort By:
Science Advances
|
March 20, 2021
Massive clonal expansion of polycytotoxic skin and blood CD8<sup>+</sup> T cells in patients with toxic epidermal necrolysis
Axel Patrice Villani, Aurore Rozieres, Benoît Bensaid, et al.
Frontiers in Immunology
|
February 3, 2025
Therapeutic plasma exchange accelerates immune cell recovery in severe COVID-19
Aurelie Guironnet-Paquet, Hind Hamzeh-Cognasse, Frederic Berard, et al.
Contact Dermatitis
|
June 18, 2023
Hand eczema in glove-wearing patients
Aude Clément, Marie-Christine Ferrier le Bouëdec, Marie-Noëlle Crépy, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 13, 2024
Switching From Dupilumab to Tralokinumab or Janus Kinase Inhibitors in Cases of Ocular and/or Facial Adverse Events in Patients With Atopic Dermatitis: A Multicenter Retrospective Study
Alexandre Beyrouti, Juliette Deuze, Eric Fontas, et al.
Contact Dermatitis
|
February 25, 2022
Multiple cases of sensitization to an antiseptic containing chlorhexidine digluconate/benzalkonium chloride/benzyl alcohol with different profiles of sensitization in adults and children
Charlotte Beaumont, Anne-Sophie Darrigade, Annick Barbaud, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 2, 2023
Multicenter prospective observational study of dupilumab-induced ocular events in atopic dermatitis patients
Ingrid Costedoat, Martin Wallaert, Aurelie Gaultier, et al.
Journal of the American Academy of Dermatology
|
August 15, 2017
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council
Eric L Simpson, Marjolein Bruin-Weller, Carsten Flohr, et al.
Journal of the American Academy of Dermatology
|
March 3, 2019
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort
Sarah Faiz, Jonathan Giovannelli, Céline Podevin, et al.
Nature Communications
|
October 22, 2020
Early-onset autoimmunity associated with SOCS1 haploinsufficiency
Jérôme Hadjadj, Carla Noemi Castro, Maud Tusseau, et al.
The World Allergy Organization Journal
|
April 24, 2026
The definition of response and inadequate response to topical corticosteroid treatment in atopic dermatitis and related skin inflammatory diseases: A GA<sup>2</sup>LEN ADCARE statement paper
Torsten Zuberbier, Mohamed Abuzakouk, Irena Angelova Fischer, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 111) with videos related to
Sort By:
Page
of 12
Science Advances
|
March 20, 2021
Massive clonal expansion of polycytotoxic skin and blood CD8<sup>+</sup> T cells in patients with toxic epidermal necrolysis
Axel Patrice Villani, Aurore Rozieres, Benoît Bensaid, et al.
Frontiers in Immunology
|
February 3, 2025
Therapeutic plasma exchange accelerates immune cell recovery in severe COVID-19
Aurelie Guironnet-Paquet, Hind Hamzeh-Cognasse, Frederic Berard, et al.
Contact Dermatitis
|
June 18, 2023
Hand eczema in glove-wearing patients
Aude Clément, Marie-Christine Ferrier le Bouëdec, Marie-Noëlle Crépy, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 13, 2024
Switching From Dupilumab to Tralokinumab or Janus Kinase Inhibitors in Cases of Ocular and/or Facial Adverse Events in Patients With Atopic Dermatitis: A Multicenter Retrospective Study
Alexandre Beyrouti, Juliette Deuze, Eric Fontas, et al.
Contact Dermatitis
|
February 25, 2022
Multiple cases of sensitization to an antiseptic containing chlorhexidine digluconate/benzalkonium chloride/benzyl alcohol with different profiles of sensitization in adults and children
Charlotte Beaumont, Anne-Sophie Darrigade, Annick Barbaud, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 2, 2023
Multicenter prospective observational study of dupilumab-induced ocular events in atopic dermatitis patients
Ingrid Costedoat, Martin Wallaert, Aurelie Gaultier, et al.
Journal of the American Academy of Dermatology
|
August 15, 2017
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council
Eric L Simpson, Marjolein Bruin-Weller, Carsten Flohr, et al.
Journal of the American Academy of Dermatology
|
March 3, 2019
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort
Sarah Faiz, Jonathan Giovannelli, Céline Podevin, et al.
Nature Communications
|
October 22, 2020
Early-onset autoimmunity associated with SOCS1 haploinsufficiency
Jérôme Hadjadj, Carla Noemi Castro, Maud Tusseau, et al.
The World Allergy Organization Journal
|
April 24, 2026
The definition of response and inadequate response to topical corticosteroid treatment in atopic dermatitis and related skin inflammatory diseases: A GA<sup>2</sup>LEN ADCARE statement paper
Torsten Zuberbier, Mohamed Abuzakouk, Irena Angelova Fischer, et al.
Page
of 12